Stay updated on Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.0 was added to the history. An earlier revision v3.4.3 was removed from the list.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew revision entry v3.4.3 added to the history. Old revision v3.4.2 removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedResult-related sections were added to the record, including Results Posted, Adverse Events, Baseline Characteristics, Participant Flow, and Outcome Measures, consolidating detailed trial data. The previous entry 'Results Submitted' was removed.SummaryDifference0.9%

- Check38 days agoChange DetectedA new revision entry v3.4.2 was added to the history, and the previous v3.4.1 revision was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded indicators that results have been submitted (Results Submitted) and that the page was updated to Revision: v3.4.1. Deleted items include the older 'No Results Posted' notice, the earlier Revision: v3.4.0, and a government funding/status notice.SummaryDifference0.6%

- Check52 days agoChange DetectedA site-wide notice was added stating that information may be out of date due to a lapse in government funding, with links to cc.nih.gov and opm.gov and noting that the NIH Clinical Center remains open.SummaryDifference0.4%

Stay in the know with updates to Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.